Used as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of targeted cancer therapies. It plays a role in modulating signaling pathways involved in cell proliferation and survival. Its structure allows for selective binding to specific enzyme targets, making it valuable in pharmaceutical research for designing drugs with improved efficacy and reduced side effects. Commonly utilized in the preparation of active pharmaceutical ingredients (APIs) for oncology drugs, especially those targeting tyrosine kinases. Also employed in structure-activity relationship (SAR) studies to optimize drug candidates during early-stage drug discovery.